文献速递临床生化质量管理与危急值

临床实验室自上而下法评估测量不确定度的实践考量

Practical Considerations for Clinical Laboratories in Top-down Approach for Assessing the Measurement Uncertainty of Clinical Chemistry Analytes.
PubMed 文献 · Ann Lab Med · 2022-01-01

该研究使用自上而下法基于室内质控数据估计14项临床生化分析物的测量不确定度,并评估试剂批号变更的影响。结果显示按批号分组计算的测量不确定度均低于总体值但差异很小,模拟表明均值偏移越大测量不确定度差异越大,质控品批号不同时多数分析物均值与测量不确定度有统计学显著差异。结论认为批号变更是影响测量不确定度估计的关键因素,不应忽视。

要点

  • 按试剂批号分组计算的测量不确定度均低于总体值,但平均差异很小。
  • 模拟显示均值偏移程度越大,测量不确定度差异越大。
  • 质控品批号不同时多数分析物均值与测量不确定度存在统计学显著差异。

核心结论

  • 室内质控数据中的批号变更是影响测量不确定度估计的关键因素,在测量不确定度估计中不应被忽视。

研究设计与样本

  • 使用自上而下法基于室内质控数据估计14项临床生化分析物的测量不确定度。
  • 比较按试剂批号变更分组与整体数据两种测量不确定度估计方法。
  • 通过随机生成数据模拟试剂批号变更,并用统计学方法比较两个室内质控数据集(不同质控品批号)的均值与测量不确定度。

主要发现

  • 按批号分组计算的所有测量不确定度值均低于总体值,但平均差异很小。
  • 模拟显示均值偏移程度增加越大,测量不确定度差异越大。
  • 室内质控数据比较中,多数分析物的均值与测量不确定度存在统计学显著差异。
  • 测量不确定度计算方法引起的差异很小,提示临床实验室室内质控数据未见显著偏移。
  • 模拟结果证明试剂批号变更前后室内质控结果显著变化可导致测量不确定度出现明显差异。

关键数值与推荐

  • 为估计测量不确定度收集室内质控数据时,质控品批号应分开处理。

临床怎么用

  • 临床实验室采用自上而下法估计测量不确定度时,应关注并处理室内质控数据中的试剂批号变更。
  • 收集用于测量不确定度估计的室内质控数据时,质控品批号应分开处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The top-down (TD) approach using internal quality control (IQC) data is regarded a practical method for estimating measurement uncertainty (MU) in clinical laboratories. We estimated the MU of 14 clinical chemistry analytes using the TD approach and evaluated the effect of lot changes on the MU. METHODS: MU values were estimated using subgrouping by reagent lot changes or using the data as a whole, and both methods were compared. Reagent lot change was simulated using randomly generated data, and the mean values and MU for two IQC datasets (different QC material lots) were compared using statistical methods. RESULTS: All MU values calculated using subgrouping were lower than the total values; however, the average differences were minimal. The simulation showed that the greater the increase in the extent of the average shift, the larger the difference in MU. In IQC data comparison, the mean values and MU exhibited statistically significant differences for most analytes. The MU calculation methods gave rise to minimal differences, suggesting that IQC data in clinical laboratories show no significant shift. However, the simulation results demonstrated that notable differences in the MU can arise from significant variations in IQC results before and after a reagent lot change. Additionally, IQC material lots should be treated separately when IQC data are collected for MU estimation. CONCLUSIONS: Lot changes in IQC data are a key factor affecting MU estimation and should not be overlooked during MU estimation.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Gu H, Lee J, Hong J, et al. Practical Considerations for Clinical Laboratories in Top-down Approach for Assessing the Measurement Uncertainty of Clinical Chemistry Analytes. Ann Lab Med. 2022. PMID: 35765871. doi:10.3343/alm.2022.42.6.630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。